Announcements Trials

Browse Landscape

Phase

Phase NA 17 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9 Gastrointestinal 4 Thoracic 3 Lymphoid 3 Genitourinary 3 Plasma cell 1 Other hematologic neoplasm 1 Other 1 Gynecologic 1 CNS 1

Conditions

Brain Neoplasms 133 Glioblastoma 92 Astrocytoma 44 Neuroblastoma 40 Glioma 40 Central Nervous System Neoplasms 38 Neoplasms 26 Breast Neoplasms 25 Neoplasm Metastasis 24 Oligodendroglioma 20 Gliosarcoma 19 Carcinoma, Non-Small-Cell Lung 18 Lymphoma, Follicular 14 Recurrence 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Medulloblastoma 13 Burkitt Lymphoma 13 Testicular Neoplasms 12 Lymphoma, T-Cell, Cutaneous 12 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Hodgkin Disease 12 Sezary Syndrome 11 Primary Myelofibrosis 11 Mycosis Fungoides 11 Leukemia, Myeloid, Chronic-Phase 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Motor Activity × CNS × Clear all

NCT06159335 2026-02-03

18F-FLUC PET/MR in Patients With Brain Mets

University of Wisconsin, Madison

Phase 3 Recruiting

Brain Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡